GlassScriptPhysician profile
Evelyn Martindale
NPI 1518210319
$1,464.84
in general payments reported to CMS, 2019-2025
9 companies · $444 in 2025
The $444 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $167 · 2022: $48.19 · 2023: $345 · 2024: $460 · 2025: $444.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,249.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $358.86 | 2021-2025 | |
| Medtronic, INC. | $272.06 | 2022-2025 | Symplicity G3, Linq II |
| Boehringer Ingelheim Pharmaceuticals, INC. | $268.05 | 2021-2025 | Jardiance |
| Abiomed | $203.80 | 2024-2025 | Impella |
| Astrazeneca Pharmaceuticals LP | $144.25 | 2022-2024 | Lokelma, Brilinta |
| Pfizer INC. | $88.09 | 2024 | |
| Alnylam Pharmaceuticals INC. | $76.86 | 2023 | Onpattro |
| Novo Nordisk INC | $37.45 | 2024 | Wegovy |
| Edwards Lifesciences Corporation | $15.42 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evelyn Martindale listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.